Lapatinib and gemcitabine for metastatic pancreatic cancer: A phase II study

被引：0
|
作者：
Safran, H.
Miner, T.
Bahary, N.
Whiting, S.
Lopez, C.
Sun, W.
Charpentier, K.
Charpentier, K.
Shipley, J.
Anderson, E.
McNulty, B.
机构：
[1] Brown Univ, Oncol Grp, Providence, RI 02912 USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[3] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[5] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA
[6] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15653
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase II study of pirfenidone combined with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer
    Guo, Guifang
    Li, Shengping
    Mao, Yize
    Yang, Qiuxia
    Yao, Zehui
    Wang, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer.
    Morizane, C.
    Okusaka, T.
    Furuse, J.
    Ishii, H.
    Ueno, H.
    Ikeda, M.
    Najima, M.
    Hirokawa, S.
    Nakachi, K.
    Ogura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 206S - 206S
  • [33] PHASE II STUDY OF GEMCITABINE + TH-302 VS GEMCITABINE ALONE IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC PANCREATIC CANCER
    Ryan, D.
    Reddy, S.
    Bahary, N.
    Uronis, H.
    Sigal, D. S.
    Cohn, Allen
    Schelman, W. R.
    Chiorean, E. G.
    Rosen, P. J.
    Ulrich, B.
    Dragovich, T.
    Del Prete, S.
    Rarick, M.
    Eng, C.
    Kroll, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 8 - 8
  • [34] A phase II trial of pharmacological ascorbate, gemcitabine, and nabpaclitaxel for metastatic pancreatic cancer.
    Kasi, Pashtoon Murtaza
    Bodeker, Kellie
    Berg, Daniel James
    Chandrasekharan, Chandrikha
    Sharif, Saima
    Smith, Brian J.
    Vollstedt, Sandy
    Brown, Heather
    Chandler, Meghan
    Cullen, Joseph J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [35] Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study
    Katrina S. Pedersen
    George P. Kim
    Nathan R. Foster
    Andrea Wang-Gillam
    Charles Erlichman
    Robert R. McWilliams
    Investigational New Drugs, 2015, 33 : 963 - 968
  • [36] Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study
    Pedersen, Katrina S.
    Kim, George P.
    Foster, Nathan R.
    Wang-Gillam, Andrea
    Erlichman, Charles
    McWilliams, Robert R.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (04) : 963 - 968
  • [37] Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
    Melnik, Marianne K.
    Webb, Craig P.
    Richardson, Patrick J.
    Luttenton, Charles R.
    Campbell, Alan D.
    Monroe, Thomas J.
    O'Rourke, Timothy J.
    Yost, Kathleen J.
    Szczepanek, Connie M.
    Bassett, Michelle R.
    Truszkowski, Kimberly J.
    Stein, Phyllis
    Van Brocklin, Matthew W.
    Davis, Alan T.
    Bedolla, Gabriela
    Vande Woude, George F.
    Koo, Han-Mo
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (08) : 2423 - 2429
  • [38] Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer
    Van Cutsem, Eric
    Hidalgo, Manuel
    Canon, Jean-Luc
    Macarulla, Teresa
    Bazin, Igor
    Poddubskaya, Elena
    Manojlovic, Nebojsa
    Radenkovic, Dejan
    Verslype, Chris
    Raymond, Eric
    Cubillo, Antonio
    Schueler, Armin
    Zhao, Charles
    Hammel, Pascal
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (08) : 2053 - 2064
  • [39] Phase II study of gemcitabine plus cisplatin in metastatic breast cancer
    Fuentes, Homero
    Calderillo, German
    Alexander, Francisco
    Ramirez, Marcelino
    Avila, Enrique
    Perez, Leonel
    Aguirre, Guillermo
    Onate-Ocana, Luis F.
    Gallardo, Dolores
    Otero, Jorge
    ANTI-CANCER DRUGS, 2006, 17 (05) : 565 - 570
  • [40] Phase I results from a study of lapatinib with gemcitabine and cisplatin (GC) in advanced/metastatic bladder cancer
    Daugaard, Gedske
    Sengelov, Lisa
    Agerbaek, Mads
    Sternberg, Cora N.
    Van Herpen, Carla
    Collette, Sandra
    Marreaud, Sandrine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
12345